The design of cyclometalated iridium(iii)–metformin complexes for hypoxic cancer treatment

Cytometalated iridium(iii)–metformin conjugates were synthesized capable of overcoming hypoxia via mitochondrial respiration inhibition, and exhibiting anti-metastasis and anti-inflammatory activities.